FDA Inspection 1216990 — Mainstay Medical Limited US, Inc.
The FDA completed an inspection of Mainstay Medical Limited US, Inc. on June 30, 2023 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 30, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Minneapolis, MN (United States)